Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Napp Pharmaceuticals Ltd Shortlisted for HSJ's Best Pharmaceutical Partnership with the NHS Award

Napp Pharmaceuticals
Posted on: 12 Mar 18

Two of Napp’s collaborative partnerships are nominated as HSJ Partnership Awards finalists for outstanding examples of industry collaborations

Cambridge UK: 09 March – The inaugural HSJ Partnership Awards nominated two of Napp’s partnership case studies for the Best Pharmaceutical Partnership with the NHS award category. Napp was nominated for its partnership with the NICE Office for Market Access (NICE OMA) around the implementation of biosimilars in oncology care, as well as its collaboration with the Ards GP Federation in Northern Ireland for an Asthma Therapeutic Review Service across 16 practices.

Commenting on the shortlist, Paul Clark, Director of Biosimilars at Napp, said: “At Napp, working in partnership is ingrained within everything we do and we aim to embody this both internally and externally. We have been working with the NHS for many years and continue to work in close collaboration to deliver value-adding medicines that improve patient outcomes. We are delighted to have been nominated for the HSJ’s Best Pharmaceutical Partnership with the NHS for not one, but two examples of our work in areas that are of great interest to the NHS: the treatment of asthma and the uptake of biosimilars. This recognition inspires us to continue finding innovative ways to work in partnership with the NHS.”

For the award nominations, Napp worked with the NICE OMA to organise a meeting between NHS and industry stakeholders, which facilitated the sharing of knowledge and ideas around effectively and efficiently implementing biosimilars into oncology pathways. Working in collaboration with Ards GP Federation, Northern Ireland and Screen Clinical (an independent, non-promotional clinical services company) Napp helped to develop and deliver an Asthma Therapeutic Review Service across 16 practices, which resulted in greater clinical attention and education for patients and HCPs.

The HSJ, the well-respected trade publication on all matters of health in the UK, announced the new awards in May 2017, to recognise outstanding partnerships at a time when demands are high on the NHS to deliver greater quality care with increased efficiency. The HSJ Partnership Awards aim to highlight how individuals and companies are aligning with essential savings happening in the NHS and celebrate how they are helping to make a difference. There are 19 award categories, recognising excellent healthcare partnerships across a variety of sectors. The winners were revealed on 8th March 2018 at a ceremony at Banking Hall in the City of London.

-Ends-

 

Notes to editors:

About Napp Pharmaceuticals Ltd

Napp Pharmaceuticals Ltd is a UK pharmaceutical company based in the heart of the Cambridge science community, and part of a worldwide network of independently associated companies across 48 countries. Napp has grown up with the NHS, providing innovative medicines to patients in the UK since the 1920s. Napp is committed to improving patient outcomes and ensuring the sustainability of healthcare. At Napp, we are proud of our heritage, which began in the treatment of chronic pain and has expanded into respiratory medicine, oncology and inflammatory disorders.

For more information, please visit www.napp.co.uk

Editor's Details

Izzie Marshall
Firstlight PR
izzie.marshall@firstlightpr.com

Last updated on: 12/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.